Evidence map›Paper›PMID 40290264›Full record

ArticleEnvironmental health insights2025

Global Research Hotspots and Progress on Acrylamide: Visualization Analysis.

Shaher Zyoud, Sa'ed H Zyoud

Abstract read
In one paragraph

Article in Environmental health insights, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shaher ZyoudDepartment of Building Engineering & Environment, Palestine Technical University (Kadoorie), Palestine.
Sa'ed H ZyoudPoison Control and Drug Information Center (PCDIC), An-Najah National University, Nablus, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acrylamide is a contaminant prevalent in many commonly consumed foods, contributing to unavoidable human exposure. It is recognized as likely to be carcinogenic to humans as well, provoking global concerns. Numerous studies have investigated the impacts of acrylamide formation on food and drink, nutrition, and health. The intent of this analysis is to quantify global acrylamide research, evaluate recent developments, and recognize emerging trends, along with assessing research dynamics as an indicator of innovation among the scientific community. The Scopus database was used to perform an in-depth investigation of scientific publications on acrylamide from 1949 to 2023. Exploring prominent topics and the knowledge network related to the topic was conducted via VOSviewer version 1.6.20. Additionally, using SciMAT software, intellectual analysis was conducted to identify both driving and emerging themes in acrylamide-related research. A total of 11 880 publications on acrylamide were identified, with 10 720 (90.24%) being original articles. The leading contributors in terms of publication output were China (n = 2452; 20.64%), followed by the USA (n = 1564; 13.16%), and India (n = 952; 8.01%). The predominant themes were associated with (a) the functionalization of acrylamide polymers and (b) the formation and mitigation of acrylamide in food and drinks. Driving themes that will continue to shape the future of acrylamide research involve unraveling the synthesis of acrylamide; deploying acrylamide in nanocomposites to increase contaminant removal; investigating the genotoxicity of acrylamide, as well as its carcinogenic, reproductive, and neurotoxic effects; and researching the adsorption characteristics of acrylamide in aqueous solutions. In particular, an increased focus has been placed on understanding the formation and mitigation of acrylamide in recent years, signifying increased attention and alignment with the latest scientific advancements in this field. The creation of research plans in this way is significant, particularly in shaping future health policies.

Indexed as

acrylamidecarcinogeneticdietary habitshealth risksnanocompositesvisualization

Identifiers

PMID40290264
PMCPMC12033651

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.